Table 3.

The distribution of the -29G>A genotypes observed in the studied groups

-29G>A genotypes	Count per group (%)
	Controln (%)	POFn (%)	DORn (%)
Wild type	54 (69.2%)	48 (58.5%)	24 (46.15)
Heterozygote	16 (20.5%)	26 (31.7%)	24 (46.15)
Full mutation	8 (10.3%)	8 (9.8%)	4 (7.7)
Total	78	82	52

The difference between wild type, heterozygote and full mutation was significant (P=0.04) among the 3 groups and also between the DOR patients with the control group (P=0.008, statistical test: Chi-square test). POF; Premature ovarian failure and DOR; Diminished ovarian reserve.